1 Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging
T. Marsden, N. McCartan, J. Hadley, S. Tuck, L. Brown, A.J. Haire, C.L. Moss, S. Green, M. van Hemelrijck, T. Coolen, A. Santaolalla, E. Isaac, G. Brembilla, D. Kopcke, F. Giganti, H. Sidhu, S. Punwani, M. Emberton, C.M. Moore, ReIMAGINE Study Group
European Urology Focus 2021, 7 (3): 503-505
PubMed: 33896710
2 An update from the ReIMAGINE Prostate Cancer Risk Study (NCT04060589): A prospective cohort study in men with a suspicion of prostate cancer who are referred onto a magnetic resonance imaging–based diagnostic pathway with donation of tissue, blood, and urine for biomarker analyses
T. Marsden, H.U. Ahmed, M. Emberton, ReIMAGINE Study Group
European Urology 2021, 80 (4): 398-399
PubMed: 34218972
3 ReIMAGINE Prostate Cancer Screening Study: protocol for a single- centre feasibility study inviting men for prostate cancer screening using MRI
T. Marsden, D.J. Lomas, N. McCartan, J. Hadley, S. Tuck, L. Brown, A. Haire, C.L. Moss, S. Green, M. Van Hemelrijck, T. Coolen, A. Santaolalla, E. Isaac, G. Brembilla, D. Kopcke, F. Giganti, H. Sidhu, S. Punwani, M. Emberton, C.M. Moore, ReIMAGINE Study Group
BMJ Open 2021, 11 (9): e048144
PubMed: 34593491
4 The ReIMAGINE prostate cancer risk study protocol: A prospective cohort study in men with a suspicion of prostate cancer who are referred onto an MRI-based diagnostic pathway with donation of tissue, blood and urine for biomarker analyses
T. Marsden, N. McCartan, L. Brown, M. Rodriguez-Justo, T. Syer, G. Brembilla, M. Van Hemelrijck, T. Coolen, G. Attard, S. Punwani, C.M. Moore, H.U. Ahmed, M. Emberton, ReIMAGINE Study Group
PLoS ONE 2022, 17 (2): e025967211
PubMed: 35202397